Related Experiment Video
Updated: May 4, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
14.1K
Carbamazepine derivatives with P2X4 receptor-blocking activity
Maoqun Tian1, Aliaa Abdelrahman1, Stephanie Weinhausen1
1PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany.
Bioorganic & Medicinal Chemistry
|January 14, 2014
Summary
Researchers developed novel carbamazepine derivatives as potential P2X4 receptor antagonists for treating neuropathic pain and inflammatory diseases. The most potent compound, N,N-diisopropyl-5H-dibenz[b,f]azepine-5-carboxamide, showed significant P2X4 inhibition.
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Pharmacology
Background:
- P2X4 receptor antagonists offer potential for treating neuropathic pain and inflammatory conditions.
- The P2X4 receptor is an ATP-activated cation channel crucial in inflammatory pathways.
Purpose of the Study:
- To design, synthesize, and evaluate novel carbamazepine derivatives as P2X4 receptor antagonists.
- To investigate the structure-activity relationships of these novel compounds.
- To assess selectivity across species and P2 receptor subtypes.
Main Methods:
- Synthesis of 47 carbamazepine derivatives, including 32 novel compounds.
- Assay of ATP-induced calcium influx in cells expressing the human P2X4 receptor.
- Determination of species and receptor subtype selectivity for key derivatives.
Main Results:
- Identified potent P2X4 receptor antagonists from the carbamazepine derivative series.
- The most effective compound, N,N-diisopropyl-5H-dibenz[b,f]azepine-5-carboxamide (34), demonstrated an allosteric inhibition mechanism with an IC50 of 3.44μM.
- Established initial structure-activity relationships for P2X4 antagonism.
Conclusions:
- Novel carbamazepine derivatives show promise as P2X4 receptor antagonists.
- The study contributes valuable structure-activity relationship data for P2X4 antagonist development.
- These findings may pave the way for new therapeutic strategies for pain and inflammation.
Keywords:
HeterocyclesInflammationLigand-gated ion channelNegative allosteric modulatorNeuropathic painP2X4 receptorStructure–activity relationshipSynthesisTricyclicsMore Related Videos
Related Concept Videos
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.8K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.8K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.7K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
01:08Antiepileptic Drugs: Sodium Channel Blockers
2.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.4K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K